• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺神经内分泌肿瘤患者术后胰瘘发生的预测因素

Predicting Factor for Occurrence of Postoperative Pancreatic Fistula in Patients with Pancreatic Neuroendocrine Tumors.

作者信息

Vlad Nutu, Andriesi-Rusu Florina Delia, Chicos Andrei, Trofin Ana Maria, Cadar Ramona, Zabara Mihai Lucian, Ciobanu Delia, Costache Mircea, Lupascu-Ursulescu Corina, Vasilescu Alin Mihai, Bradea Costel, Blaj Mihaela, Lovin Oana Maria, Ciumanghel Adi Ionut, Crumpei Felicia, Lupascu Cristian Dumitru

机构信息

First Surgical Clinic, "St. Spiridon" Hospital Iasi, Independentei str, no 1, 700111 Iasi, Romania.

Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania.

出版信息

Diagnostics (Basel). 2025 Jan 23;15(3):268. doi: 10.3390/diagnostics15030268.

DOI:10.3390/diagnostics15030268
PMID:39941198
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11818008/
Abstract

Neuroendocrine tumors are tumors that can develop in any organ but show a predilection for the pancreas. These can be secreting or non-secreting tumors, or they can be well differentiated or poorly differentiated, or neuroendocrine carcinomas. Surgical treatment is the only treatment with curative intent, but postoperatively, it shows an increased incidence of postoperative pancreatic fistulas. We carried out a retrospective study which included 26 patients with neuroendocrine tumors and neuroendocrine carcinomas, for whom we performed cephalic duodenopancreatectomies, distal pancreatic resections or enucleation. In our study group, the incidence of pancreatic fistulas was 28%, and a series of risk factors such as the type of surgery (duodenopancreatectomy and enucleation were associated with the highest incidence of POPF), histological type (pancreatic neuroendocrine carcinomas were associated with lowest incidence of POPF), obesity (the incidence of POPF was double in the obese group), functioning tumors (with = 0.032 and AUC = 746) and dynamic hemoglobin value (AUC = 705 shows a good predicting power, with a cutoff value = 1.8 drop hemoglobin) were indicated. Neuroendocrine tumors show a predisposition for the occurrence of postoperative complications, especially postoperative pancreatic fistulas. There are multiple risk factors that interact in the production of postoperative complications.

摘要

神经内分泌肿瘤是可发生于任何器官但好发于胰腺的肿瘤。这些肿瘤可以是分泌性或非分泌性肿瘤,也可以是高分化或低分化的,或是神经内分泌癌。手术治疗是唯一具有治愈意图的治疗方法,但术后胰瘘的发生率会增加。我们进行了一项回顾性研究,纳入了26例神经内分泌肿瘤和神经内分泌癌患者,对他们实施了胰头十二指肠切除术、胰腺远端切除术或肿瘤摘除术。在我们的研究组中,胰瘘的发生率为28%,并且指出了一系列危险因素,如手术类型(十二指肠胰腺切除术和肿瘤摘除术与术后胰瘘的最高发生率相关)、组织学类型(胰腺神经内分泌癌与术后胰瘘的最低发生率相关)、肥胖(肥胖组术后胰瘘的发生率是对照组的两倍)、功能性肿瘤(P = 0.032,曲线下面积 = 746)和动态血红蛋白值(曲线下面积 = 705显示出良好的预测能力,截断值 = 血红蛋白下降1.8)。神经内分泌肿瘤术后易发生并发症,尤其是术后胰瘘。术后并发症的发生存在多种相互作用的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/d31475aef2ef/diagnostics-15-00268-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/3d948c316afb/diagnostics-15-00268-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/5189e289d6cf/diagnostics-15-00268-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/8db8927c13cd/diagnostics-15-00268-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/a380f41fb165/diagnostics-15-00268-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/edf03f022b0c/diagnostics-15-00268-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/5c92470133df/diagnostics-15-00268-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/7871586b3534/diagnostics-15-00268-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/d31475aef2ef/diagnostics-15-00268-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/3d948c316afb/diagnostics-15-00268-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/5189e289d6cf/diagnostics-15-00268-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/8db8927c13cd/diagnostics-15-00268-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/a380f41fb165/diagnostics-15-00268-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/edf03f022b0c/diagnostics-15-00268-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/5c92470133df/diagnostics-15-00268-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/7871586b3534/diagnostics-15-00268-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eae/11818008/d31475aef2ef/diagnostics-15-00268-g009.jpg

相似文献

1
Predicting Factor for Occurrence of Postoperative Pancreatic Fistula in Patients with Pancreatic Neuroendocrine Tumors.胰腺神经内分泌肿瘤患者术后胰瘘发生的预测因素
Diagnostics (Basel). 2025 Jan 23;15(3):268. doi: 10.3390/diagnostics15030268.
2
Rate of clinically significant postoperative pancreatic fistula in pancreatic neuroendocrine tumors.胰腺神经内分泌肿瘤术后具有临床意义的胰瘘发生率
World J Surg. 2012 Jul;36(7):1517-26. doi: 10.1007/s00268-012-1598-9.
3
Assessment of preoperative risk factors for complications after distal pancreatectomy for neuroendocrine tumors.神经内分泌肿瘤胰体尾切除术后并发症的术前危险因素评估
Endokrynol Pol. 2025;76(2):182-190. doi: 10.5603/ep.102243.
4
Utility of fistula risk score in assessing the risk of postoperative pancreatic fistula occurrence and other significant complications after different types of pancreatic neuroendocrine tumor resections.瘘管风险评分在评估不同类型胰腺神经内分泌肿瘤切除术后胰瘘发生风险及其他重大并发症方面的效用。
Ann Surg Treat Res. 2022 Dec;103(6):340-349. doi: 10.4174/astr.2022.103.6.340. Epub 2022 Dec 8.
5
A comprehensive study on postoperative complications and postoperative pancreatic fistula in sporadic non-functional pancreatic neuroendocrine tumors: A retrospective cohort study.散发性无功能胰腺神经内分泌肿瘤术后并发症及术后胰瘘的综合研究:一项回顾性队列研究。
Ann Hepatobiliary Pancreat Surg. 2025 May 31;29(2):168-176. doi: 10.14701/ahbps.24-215. Epub 2025 Feb 13.
6
[Enucleation of pancreatic tumors: a multiple-center study].[胰腺肿瘤摘除术:一项多中心研究]
Khirurgiia (Mosk). 2023(2):13-20. doi: 10.17116/hirurgia202302113.
7
Predictors of post-operative pancreatic fistula formation in pancreatic neuroendocrine tumors: A national surgical quality improvement program analysis.胰腺神经内分泌肿瘤术后胰瘘形成的预测因素:国家手术质量改进计划分析。
Am J Surg. 2022 Nov;224(5):1256-1261. doi: 10.1016/j.amjsurg.2022.07.007. Epub 2022 Aug 10.
8
Significance of preoperative radiographic pancreatic density in predicting pancreatic fistula after surgery for pancreatic neuroendocrine tumors.术前胰腺影像学密度在预测胰腺神经内分泌肿瘤手术后胰瘘中的意义
Am J Surg. 2016 Jul;212(1):40-6. doi: 10.1016/j.amjsurg.2015.07.031. Epub 2015 Dec 12.
9
Risk factors for postoperative pancreatic fistula following non-traumatic, pancreatic surgery. Retrospective observational study.非创伤性胰腺手术后胰瘘的风险因素。回顾性观察性研究。
Ann Ital Chir. 2023;94:435-442.
10
Risk factors for postoperative pancreatic fistulization subsequent to enucleation.术后胰腺切除术后发生胰瘘的危险因素。
J Gastrointest Surg. 2012 Oct;16(10):1883-7. doi: 10.1007/s11605-012-1971-x. Epub 2012 Aug 8.

引用本文的文献

1
Clinicopathologic risk factors for post-operative complications after enucleation of pancreatic neoplasms.胰腺肿瘤摘除术后术后并发症的临床病理危险因素
World J Surg Oncol. 2025 Jul 22;23(1):293. doi: 10.1186/s12957-025-03920-0.

本文引用的文献

1
Recurrence-Free Survival and Disease-Specific Survival in Patients with Pancreatic Neuroendocrine Neoplasms: A Single-Center Retrospective Study of 413 Patients.胰腺神经内分泌肿瘤患者的无复发生存率和疾病特异性生存率:一项针对413例患者的单中心回顾性研究
Cancers (Basel). 2023 Dec 24;16(1):100. doi: 10.3390/cancers16010100.
2
Outcome of nonfunctioning pancreatic neuroendocrine tumors after initial surveillance or surgical resection: a single-center observational study.无功能性胰腺神经内分泌肿瘤初始监测或手术切除后的结局:一项单中心观察性研究
Ann Gastroenterol. 2023 Nov-Dec;36(6):686-693. doi: 10.20524/aog.2023.0833. Epub 2023 Oct 30.
3
Pancreatic Neuroendocrine Tumors in MEN1 Patients: Difference in Post-Operative Complications and Tumor Progression between Major and Minimal Pancreatic Surgeries.
MEN1患者的胰腺神经内分泌肿瘤:胰腺大手术与小手术术后并发症及肿瘤进展的差异
Cancers (Basel). 2023 Oct 10;15(20):4919. doi: 10.3390/cancers15204919.
4
Narrative Review of Immunotherapy in Gastroentero-Pancreatic Neuroendocrine Neoplasms.胃肠胰神经内分泌肿瘤的免疫治疗叙事性综述。
Curr Oncol. 2023 Sep 21;30(9):8653-8664. doi: 10.3390/curroncol30090627.
5
Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis.胰腺小神经内分泌肿瘤的特征及侵袭转移的危险因素。
Front Endocrinol (Lausanne). 2023 Mar 20;14:1140873. doi: 10.3389/fendo.2023.1140873. eCollection 2023.
6
Utility of fistula risk score in assessing the risk of postoperative pancreatic fistula occurrence and other significant complications after different types of pancreatic neuroendocrine tumor resections.瘘管风险评分在评估不同类型胰腺神经内分泌肿瘤切除术后胰瘘发生风险及其他重大并发症方面的效用。
Ann Surg Treat Res. 2022 Dec;103(6):340-349. doi: 10.4174/astr.2022.103.6.340. Epub 2022 Dec 8.
7
Predictors of post-operative pancreatic fistula formation in pancreatic neuroendocrine tumors: A national surgical quality improvement program analysis.胰腺神经内分泌肿瘤术后胰瘘形成的预测因素:国家手术质量改进计划分析。
Am J Surg. 2022 Nov;224(5):1256-1261. doi: 10.1016/j.amjsurg.2022.07.007. Epub 2022 Aug 10.
8
Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls.胰腺神经内分泌肿瘤:诊断与陷阱。
Virchows Arch. 2022 Feb;480(2):247-257. doi: 10.1007/s00428-021-03211-5. Epub 2021 Oct 13.
9
Risk of malignancy and prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors.散发性切除的小(≤2厘米)无功能胰腺神经内分泌肿瘤的恶性风险及预后
Gland Surg. 2021 Jan;10(1):219-232. doi: 10.21037/gs-20-582.
10
Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations.胰腺神经内分泌肿瘤:治疗挑战与研究局限
World J Gastroenterol. 2020 Jul 28;26(28):4036-4054. doi: 10.3748/wjg.v26.i28.4036.